Craft

Can-Fite BioPharma

Stock Price

₪0

2024-07-08

Market Capitalization

₪4.6 B

2024-07-08

Revenue

$743 K

FY, 2023

Can-Fite BioPharma Summary

Company Summary

Overview
Can-Fite BioPharma is a biopharmaceutical company with pharmaceutical discovery and clinical development capabilities. It has a pipeline of proprietary compounds that address autoimmune-inflammatory and liver diseases.
Type
Public
Status
Active
Founded
1994
HQ
Petah Tikva, IL | view all locations
Website
http://www.canfite.com
Cybersecurity rating
Sectors

Key People

  • Ilan Cohn, Chairman

    • Pnina Fishman, Chief Executive Officer, Director

      • Abraham Sartani, Director

        LocationsView all

        1 location detected

        • Petah Tikva, Center District HQ

          Israel

          Bareket St 10, Petah Tikva

        Can-Fite BioPharma Financials

        Summary Financials

        Revenue (FY, 2023)
        $743.0K
        Gross profit (FY, 2023)
        $743.0K
        Net income (FY, 2023)
        ($7.6M)
        Cash (FY, 2023)
        $4.3M
        EBIT (FY, 2023)
        ($8.2M)
        Enterprise value
        $4.6B

        Footer menu